Fiche du document
Date
2019
Type de document
Périmètre
Langue
Identifiant
- handle: 10670/1.wy9gc1
Source
Collection
Organisation
Licence
Cairn
Sujets proches
ConquinineCiter ce document
Shinsaku Yoshitomi et al., « Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations », Epileptic Disorders, ID : 10670/1.wy9gc1
Métriques
Partage / Export
Résumé
AimsSeveral recent studies have reported potassium sodium-activated channel subfamily T member 1 ( KCNT1) mutations in epilepsy patients on quinidine therapy. The efficacy and safety of quinidine for epilepsy treatment, however, remains controversial.